The Personal Touch
An indispensable component of personalized medicine, companion diagnostics are certain to increase in the breadth of their application to disease areas.
Read MorePosted by Elaine Sanchez Wilson | Aug 30, 2015 | Cancer, Molecular Diagnostics |
An indispensable component of personalized medicine, companion diagnostics are certain to increase in the breadth of their application to disease areas.
Read MorePosted by Steve Halasey | Aug 11, 2015 | Research |
Working with a global collaboration of stakeholders in personalized cancer medicine, HTG’s platform will contribute to the development of gene expression molecular profiling tests for multiple targeted therapies.
Read MorePosted by Steve Halasey | Jul 14, 2015 | Research |
A study led by Mayo Clinic researchers has identified a common epigenomic fingerprint and potential target for metastatic cancer therapies.
Read MorePosted by Elaine Sanchez Wilson | Jun 17, 2015 | Cancer |
Accountable Care Organizations are playing important roles in reshaping the healthcare sector of the future.
Read MorePosted by Steve Halasey | Jun 10, 2015 | Cancer, Lung Cancer, Molecular Diagnostics |
The blood-based proteomic test for patients with non-small cell lung cancer is now covered by three major national payers for a total of over 160 million covered lives.
Read More